111 related articles for article (PubMed ID: 6267280)
1. Synthesis and antiviral activity of 5-[(cyanomethylene)oxy]-2'-deoxyuridine.
Huang GF; Okada M; De Clercq E; Torrence PF
J Med Chem; 1981 Apr; 24(4):390-3. PubMed ID: 6267280
[TBL] [Abstract][Full Text] [Related]
2. 5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine.
Torrence PF; Spencer JW; Bobst AM
J Med Chem; 1978 Feb; 21(2):228-31. PubMed ID: 202709
[TBL] [Abstract][Full Text] [Related]
3. Oxime and dithiolane derivatives of 5-formyl-2'-deoxyuridine and their 5'-phosphates: antiviral effects and thymidylate synthetase inhibition.
Park JS; Chang CT; Schmidt CL; Golander Y; De Clercq E; Descamps J; Mertes MP
J Med Chem; 1980 Jun; 23(6):661-5. PubMed ID: 6248643
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5-[(methylthio)methyl]-2'-deoxyuridine, the corresponding sulfoxide and sulfone, and their 5'-phosphates: antiviral effects and thymidylate synthetase inhibition.
Schmidt CL; Chang CT; De Clercq E; Descamps J; Mertes MP
J Med Chem; 1980 Mar; 23(3):252-6. PubMed ID: 6245212
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.
Bergstrom DE; Ruth JL; Reddy PA; De Clercq E
J Med Chem; 1984 Mar; 27(3):279-84. PubMed ID: 6321735
[TBL] [Abstract][Full Text] [Related]
6. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
8. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
9. Improved synthesis and in vitro antiviral activities of 5-cyanouridine and 5-cyano-2'-deoxyuridine.
Torrence PF; Bhooshan B
J Med Chem; 1977 Jul; 20(7):974-6. PubMed ID: 195058
[TBL] [Abstract][Full Text] [Related]
10. Antiviral, antitumor, and thymidylate synthetase inhibition studies of 5-substituted styryl derivatives of 2'-deoxyuridine and their 5'-phosphates.
De Clercq E; Balzarini J; Descamps J; Bigge CF; Chang CT; Kalaritis P; Mertes MP
Biochem Pharmacol; 1981 Mar; 30(5):495-502. PubMed ID: 6261769
[No Abstract] [Full Text] [Related]
11. Selective antiviral agents. The metabolism of 5-propyl-2'-deoxyuridine and effects on DNA synthesis in herpes simplex virus type 1 infections.
Ruth JL; Cheng Y
J Biol Chem; 1982 Sep; 257(17):10261-6. PubMed ID: 6286646
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogues.
Wigerinck P; Kerremans L; Claes P; Snoeck R; Maudgal P; De Clercq E; Herdewijn P
J Med Chem; 1993 Mar; 36(5):538-43. PubMed ID: 8388474
[TBL] [Abstract][Full Text] [Related]
13. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
Lee YS; Park SM; Kim BH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1126-8. PubMed ID: 19147352
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
Holliday J; Williams MV
Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
Reefschläger J; Pein CD; Cech D
J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
[TBL] [Abstract][Full Text] [Related]
18. Prodrugs of 5-ethyl-2'-deoxyuridine, II. Syntheses and antiviral activities of 5'- and 3'-ester derivatives.
Kiefer G; Keppeler K; De Clercq E
Arch Pharm (Weinheim); 1986 Feb; 319(2):154-60. PubMed ID: 3010900
[No Abstract] [Full Text] [Related]
19. Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.
Desgranges C; De Clercq E; Razaka G; Drouillet F; Belloc I; Bricaud H
Biochem Pharmacol; 1986 May; 35(10):1647-53. PubMed ID: 3011010
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activity of the carbocyclic analogues of 5-ethyl-2'-deoxyuridine and of 5-ethynyl-2'-deoxyuridine.
Shealy YF; O'Dell CA; Arnett G; Shannon WM
J Med Chem; 1986 Jan; 29(1):79-84. PubMed ID: 3001308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
